Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The two well-known quality-assessment metrics of head and neck oncosurgery are the status of surgical margin (SM) and lymph node yield (LNY). While the clinical importance of LNY has been well-established, several unresolved controversies around the SM have deterred its practical application.

Methods: This article reviews some of the issues with the SM and ongoing efforts to improve its clinical application and reliability.

Results: Several variations exist around SM, regarding its definition, designation, procurement, handling, and pathological processing, which could hinder its reliability. Until newer instruments that could improve the safety of surgical resection are validated robustly and are accessible widely, the surgeons need to adhere to the standardized approach of using the SM in clinical practice.

Conclusions: Unless not available, the SM based on the surgical specimen should be given priority for all practical purposes over the tissue taken from the surgical bed; with the latter serving only as an intraoperative guide, to facilitate an appropriate margin revision whenever needed and feasible.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12382018PMC
http://dx.doi.org/10.1186/s12957-025-03993-xDOI Listing

Publication Analysis

Top Keywords

status surgical
8
head neck
8
surgical
5
assessment interpretation
4
interpretation status
4
surgical margins
4
margins resective
4
resective surgery
4
surgery head
4
neck squamous
4

Similar Publications

Hormonal receptor status and lymph nodes involvement in breast cancer: a retrospective study.

Cell Mol Biol (Noisy-le-grand)

September 2025

Assistant Professor of General Surgery, Department of Surgery, College of Medicine, University of Duhok, Kurdistan Region, Iraq.

Hormonal status and lymphatic invasion are two important prognostic factors among cases of breast cancer. This study aims to assess and evaluate the hormonal receptor status and lymph node involvement among female breast cancer patients in Duhok city, Kurdistan region, Iraq. A retrospective cross-sectional study was conducted, involving 156 diagnosed cases of breast cancer who had undergone surgical treatment and laboratory investigations at Azadi Teaching Hospital and Duhok Private Hospital for 30 months.

View Article and Find Full Text PDF

To develop a DeepSurv model for predicting survival in pancreatic adenocarcinoma patients, evaluating the benefit of surgical versus non-surgical treatment across different stages, including stage IV subcategories. Clinical data were extracted from the SEER database (2000-2020). Patients were randomly divided into a model-building group and an experimental group.

View Article and Find Full Text PDF

ObjectiveRandomized trials will ultimately determine whether stand-alone middle meningeal artery embolization (MMAE) is effective in preventing the recurrence of chronic subdural hematoma (cSDH). We therefore characterized in-hospital complications, length of stay, and discharge disposition among adults undergoing stand-alone MMAE for non-traumatic cSDH in the United States.MethodsWe conducted a retrospective cohort analysis using the National Inpatient Sample (2016-2022) to identify adult patients (≥18 years) with a primary diagnosis of nontraumatic cSDH.

View Article and Find Full Text PDF

Study Design: Retrospective cohort study.

Objective: To characterise patients admitted to a UK tertiary centre with OPLL over a 10-year period.

Summary Of Background Data: OPLL is a progressive degenerative condition that can lead to myelopathy.

View Article and Find Full Text PDF

Previous studies have shown that the pre-transplant C-reactive protein (CRP)/platelet ratio (CP ratio) is a predictor of survival. The aim of this multicenter retrospective study was to evaluate the clinical significance of CP ratio in patients with malignant lymphoma (ML) who underwent allogeneic hematopoietic stem cell transplantation (alloHCT). The cohort included patients with ML who underwent first alloHCT from 2007 to 2021.

View Article and Find Full Text PDF